Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of atherosclerosis

S Ylä-Herttuala1, J Luoma, H Kallionpää

  • 1A.I. Virtanen Institute, University of Kuopio, Finland.

Maturitas
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis.

Scientific reports·2025
Same author

BMP2 gene transfer induces pericardial effusion and inflammatory response in the ischemic porcine myocardium.

Frontiers in cardiovascular medicine·2023
Same author

SproutAngio: an open-source bioimage informatics tool for quantitative analysis of sprouting angiogenesis and lumen space.

Scientific reports·2023
Same author

Decreased Gray-White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea.

The journal of prevention of Alzheimer's disease·2022
Same author

Gene therapy for ischaemic heart disease and heart failure.

Journal of internal medicine·2021
Same author

BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF.

Angiogenesis·2020

Atherosclerosis, a major cause of cardiovascular disease, is linked to changes in lipoproteins after menopause. Hormone replacement therapy may offer protection by improving lipid profiles and vascular health.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Pathology

Background:

  • Atherosclerosis affects large and medium arteries, characterized by lipid accumulation, foam cells, and smooth muscle proliferation.
  • Plasma lipids and lipoproteins are crucial in atherosclerotic lesion development.
  • Oxidized low-density lipoprotein (LDL) is implicated in atherosclerosis pathogenesis.

Purpose of the Study:

  • To explore the role of sex steroids and hormone replacement therapy (HRT) in postmenopausal cardiovascular disease.
  • To investigate the impact of HRT on plasma lipoproteins and vascular health in postmenopausal women.

Main Methods:

  • Review of recent evidence on atherosclerosis, lipoproteins, menopause, and hormone replacement therapy.
  • Analysis of the effects of estrogens on vascular wall components and LDL metabolism.

Related Experiment Videos

Main Results:

  • Cardiovascular disease incidence rises post-menopause due to atherogenic lipoprotein changes (increased LDL, decreased HDL).
  • Hormone replacement therapy demonstrates anti-atherogenic effects on plasma lipoprotein fractions.
  • Estrogens may directly inhibit LDL degradation, oxidation, and smooth muscle cell proliferation, protecting the vascular wall.

Conclusions:

  • Sex steroids, particularly estrogens, play a significant role in influencing atherosclerosis and thrombosis post-menopause.
  • Hormone replacement therapy presents a potential strategy to mitigate postmenopausal cardiovascular risk through beneficial effects on lipids and the vascular endothelium.